Trial · NCT04574362
Results by group36
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 36
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants Who Had Freedom From Pain at 2 Hours Post-dose | Rimegepant 75 mg | 19.8 | 95% Confidence Interval 16.9 to 23.1 | Percentage of participants | |
| Percentage of Participants Who Had Freedom From Pain at 2 Hours Post-dose | Placebo | 10.7 | 95% Confidence Interval 8.5 to 13.3 | Percentage of participants | |
| Percentage of Participants Who Had Freedom From Most Bothersome Symptoms (MBS) at 2 Hours Post-dose | Rimegepant 75 mg | 50.5 | 95% Confidence Interval 46.6 to 54.3 | Percentage of participants | |
| Percentage of Participants Who Had Freedom From Most Bothersome Symptoms (MBS) at 2 Hours Post-dose | Placebo | 35.8 | 95% Confidence Interval 32.1 to 39.5 | Percentage of participants | |
| Percentage of Participants With Pain Relief at 2 Hours Post-dose | Rimegepant 75 mg | 66.5 | 95% Confidence Interval 62.8 to 70.1 | Percentage of participants | |
| Percentage of Participants With Pain Relief at 2 Hours Post-dose | Placebo | 48.5 | 95% Confidence Interval 44.7 to 52.4 | Percentage of participants | |
| Percentage of Participants Who Functioned Normally at 2 Hours Post-dose | Rimegepant 75 mg | 40.7 | 95% Confidence Interval 36.6 to 45.0 | Percentage of participants | |
| Percentage of Participants Who Functioned Normally at 2 Hours Post-dose | Placebo | 23.8 | 95% Confidence Interval 20.3 to 27.6 | Percentage of participants | |
| Percentage of Participants Who Used Rescue Medication Within 24 Hours Post-dose | Rimegepant 75 mg | 8.4 | 95% Confidence Interval 6.4 to 10.8 | Percentage of participants | |
| Percentage of Participants Who Used Rescue Medication Within 24 Hours Post-dose | Placebo | 20.0 | 95% Confidence Interval 17.1 to 23.3 | Percentage of participants | |
| Percentage of Participants Who Sustained Pain Freedom From 2 to 24 Hours Post-dose | Rimegepant 75 mg | 15.6 | 95% Confidence Interval 12.9 to 18.6 | Percentage of participants | |
| Percentage of Participants Who Sustained Pain Freedom From 2 to 24 Hours Post-dose | Placebo | 7.9 | 95% Confidence Interval 5.9 to 10.2 | Percentage of participants | |
| Percentage of Participants Who Sustained Pain Freedom From 2 to 48 Hours Post-dose | Rimegepant 75 mg | 14.9 | 95% Confidence Interval 12.2 to 17.8 | Percentage of participants | |
| Percentage of Participants Who Sustained Pain Freedom From 2 to 48 Hours Post-dose | Placebo | 7.1 | 95% Confidence Interval 5.3 to 9.3 | Percentage of participants | |
| Percentage of Participants Who Had Freedom From Pain at 15, 30, 45, 60 and 90 Minutes Post-dose | Rimegepant 75 mg | 15 minutes post-dose | 0.8 | 95% Confidence Interval 0.2 to 1.7 | Percentage of participants |
| Percentage of Participants Who Had Freedom From Pain at 15, 30, 45, 60 and 90 Minutes Post-dose | Placebo | 15 minutes post-dose | 1.5 | 95% Confidence Interval 0.7 to 2.7 | Percentage of participants |
| Percentage of Participants Who Had Freedom From Pain at 15, 30, 45, 60 and 90 Minutes Post-dose | Rimegepant 75 mg | 30 minutes post-dose | 1.1 | 95% Confidence Interval 0.4 to 2.2 | Percentage of participants |
| Percentage of Participants Who Had Freedom From Pain at 15, 30, 45, 60 and 90 Minutes Post-dose | Placebo | 30 minutes post-dose | 1.0 | 95% Confidence Interval 0.4 to 2.1 | Percentage of participants |
| Percentage of Participants Who Had Freedom From Pain at 15, 30, 45, 60 and 90 Minutes Post-dose | Rimegepant 75 mg | 45 minutes post-dose | 3.3 | 95% Confidence Interval 2.1 to 5.0 | Percentage of participants |
| Percentage of Participants Who Had Freedom From Pain at 15, 30, 45, 60 and 90 Minutes Post-dose | Placebo | 45 minutes post-dose | 2.2 | 95% Confidence Interval 1.3 to 3.6 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04574362/results